A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer

Beijing Chao-Yang Hospital, Capital Medical University, Beijing

Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing

Peking Union Medical College Hospital, Beijing

Tsinghua University Affiliated Beijing Tsinghua Changgung Hospital, Beijing

Beijing Luhe Hospital Capital Medical University, Beijing

Liaoning Cancer Hospital, Shenyang

Obstetrics & Gynecology Hospital of Fudan University, Shanghai

Nanjing Drum Tower Hospital, Nanjing

Anhui Provincial Hospital, Hefei

The Second Affiliated Hospital of Anhui Medical University, Hefei

Binzhou Medical University Hospital, Binzhou

Weifang People's Hospital, Weifang

Yantai Yuhuangding Hospital, Yantai

Qingdao Central Hospital, Qingdao

Linyi Cancer Hospital, Linyi

Tianjin Central Hospital of Gynecology Obstetrics, Tianjin

Tianjin Medical University Cancer Institute & Hospital, Tianjin

Zhejiang Cancer Hospital, Hangzhou

Taizhou Hospital of Zhejiang Province, Taizhou

Chongqing University Cancer Hospital, Chongqing

Hunan Cancer Hospital, Changsha

Sun Yat-sen University Cancer Center, Guangzhou

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

Guangxi Medical University Affiliated Tumor Hospital, Nanning

Xi'an People's Hospital, Xi’an

First Affiliated Hospital of Xi'an Jiaotong University, Xi’an

Gansu Provincial Hospital, Lanzhou

Lanzhou University Second Hospital, Lanzhou

Gansu Province Maternity and Chid-care Hospital, Lanzhou

The First Affiliated Hospital of Xinjiang Medical University, Ürümqi

Xinjiang Medical University Affiliated Tumor Hospital, Ürümqi

First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi

Henan Cancer Hospital, Zhengzhou

Affiliated Hospital of Hebei University, Baoding

Fudan University Shanghai Cancer Center, Shanghai

Second Hospital of Shanxi Medical University, Taiyuan